Redx Pharma (LSE:REDX) EV-to-EBITDA : -1.93 (As of May. 21, 2024)

Redx Pharma EV-to-EBITDA Chart

Redx Pharma Annual Data
	Trend	Sep14	Sep15	Sep16	Sep17	Sep18	Sep19	Sep20	Sep21	Sep22	Sep23
EV-to-EBITDA		Get a 7-Day Free Trial					-1.80	-13.72	-11.69	-10.11	-2.89

Redx Pharma Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-EBITDA	Get a 7-Day Free Trial															-11.69	-	-10.11	-	-2.89

Competitive Comparison of Redx Pharma's EV-to-EBITDA

For the Biotechnology subindustry, Redx Pharma's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redx Pharma's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Redx Pharma's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Redx Pharma's EV-to-EBITDA falls into.

Redx Pharma EV-to-EBITDA Calculation

Redx Pharma's EV-to-EBITDA for today is calculated as:

Redx Pharma's current Enterprise Value is £57.94 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Redx Pharma's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was £-30.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redx Pharma  (LSE:REDX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Redx Pharma's PE Ratio for today is calculated as:

Redx Pharma's share price for today is £0.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Redx Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.099.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Redx Pharma EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Redx Pharma's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Redx Pharma (LSE:REDX) Business Description